Komiya Masafumi, Asano Shigehiro, Koike Nobuyuki, Koga Erina, Igarashi Junetsu, Nakatani Shogo, Isobe Yoshiaki
Research Division, Dainippon Sumitomo Pharma Co., Ltd.
Chem Pharm Bull (Tokyo). 2013;61(10):1094-7. doi: 10.1248/cpb.c13-00493.
Based on the structure activity relationship of 2-(4-phenoxybenzoyl)-5-hydroxyindole (1), a novel structural class of Ca²⁺/calmodulin-dependent protein kinase II (CaMKII) inhibitors were synthesized. We show in this study that the acidic proton at the N(1)-position of the indole moiety is not essential for CaMKII inhibitory activity. Among the synthesized compounds, we found the benzofuran and benzothiazole derivative as promising scaffolds for the developement of potent CaMKII inhibitors. In particular, compounds 8 and 14 inhibited CaMKII with IC₅₀ values of 24 nM and 32 nM, respectively.
基于2-(4-苯氧基苯甲酰基)-5-羟基吲哚(1)的构效关系,合成了一类新型的钙调蛋白依赖性蛋白激酶II(CaMKII)抑制剂。我们在本研究中表明,吲哚部分N(1)位的酸性质子对CaMKII抑制活性并非必需。在合成的化合物中,我们发现苯并呋喃和苯并噻唑衍生物是开发强效CaMKII抑制剂的有前景的骨架。特别是,化合物8和14分别以24 nM和32 nM的IC₅₀值抑制CaMKII。